Abano shares valued at $8.30-$10.05 by Grant Samuel, exceeding Archer price

Mon, 25 Nov 2013

Nov. 26 (BusinessDesk) - Abano Healthcare is worth $8.30 to $10.05 a share for 100 percent of the company, a premium of as much as 46 percent to recent trading and well north of the takeover price proposed by Archer Capital and shareholders Peter Hutson and James Reeves, Grant Samuel says. The healthcare investor released the adviser’s report at its annual meeting, saying the Archer consortium’s indicative price range of $6.97 to $7.14 a share “significantly undervalues” Abano and its portfolio of businesses and it said there are rival opport...
BRIAN GAYNOR: Aluminium smelter reaches use by date
Brian Gaynor | Sat, 11 Jul 2020

The negative market reaction to Rio Tinto’s announcement that it was winding down the Tiwai Point aluminium smelter was overdone, particularly for investors with long-term perspectives. The smelter...

MARKET CLOSE: NZ shares fall as energy sector sell-off continues
Dan Brunskill | Fri, 10 Jul 2020

New Zealand shares fell as energy stocks declined for a second day following the announcement Rio Tinto’s New Zealand aluminium smelter will close. Chorus led the market lower on the risk of more r...

Metlifecare and EQT enter new $6 per share takeover agreement
Jenny Ruth | Fri, 10 Jul 2020

Metlifecare said it has entered into a new scheme of arrangement with Swedish company EQT to buy all its shares for $6 each, a dollar less than the earlier deal EQT had repudiated, but only four of th...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.

Sponsored: What’s next for the future of the office?

Think everyone is going to keep working from home? No so fast, says Milford Asset Management.